Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of parkinsons disease

Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of parkinsons disease

US Patent 10155030 · Granted Dec 18, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dead antigen stimulated immature heterogenous dendritic cells as therapeutics fo2025
Compositions and methods relating to novel sulfono-gamma-AA peptides2024
Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer's dis2022
Compounds and methods for reducing or inhibiting aggregation of proteins in a su2022
Ultra-low dose THC as a potential therapeutic and prophylactic agent for Alzheim2021
Compounds for the treatment of neurodegenerative diseases2020
Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for trea2020
Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for trea2020
Compounds for the treatment of neurodegenerative diseases2020
Prevention and treatment of brain diseases and disorders related to abnormal pro2018
Methods of synthesizing γ-AApeptides, γ-AApeptide building blocks, γ-AApeptide l2018
Methods of synthesizing γ-aapeptides, γ-aapeptide building blocks, γ-aapeptide l2017